Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Philip J. Mease, Bernard S. Goffe, James M. Metz et al. · The Lancet · 2000 · 1.5K citations

Medicine, Immunology, Pharmacotherapy +6

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Désirée van der Heijde, Alan Kivitz, Michael Schiff et al. · Arthritis & Rheumatism · 2006 · 878 citations

Life Sciences, Immunology, Pharmacotherapy +13

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens et al. · Arthritis & Rheumatism · 2005 · 861 citations

Medicine, Pharmacology, Pharmacotherapy +14

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism · 2003 · 763 citations

Medicine, Immunology, Pharmacotherapy +8